Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

Initiation of share buyback program

CONTXRegulatoriskt pressmeddelande2026-09-09 17:40
Discuss
Ladda ner börsmeddelandet

Oslo, 9 September 2026 
The Board of Directors of ContextVision AB ("ContextVision" or "the Company") has resolved to initiate a share buyback program to be executed in accordance with the authorization granted to the Board of Directors by the Annual General Meeting of ContextVision held on 12 May 2026 (“the Authorization”).

The share buyback program will commence on 10 September 2026 and end no later than 29 January 2027. The buyback program covers purchases for a maximum consideration of NOK 12 million, or a maximum of 2,000,000 shares in accordance with the Authorization. The purpose of the program is to reduce the capital of the Company and/or meet obligations arising from the Company's long-term incentive programs (LTIP). 

ContextVision has engaged DNB Carnegie, a part of DNB Bank ASA, to manage and carry out the share repurchases in the market. DNB Carnegie will make its trading decisions independently of, and uninfluenced by ContextVision. The share buyback program will be carried out in accordance with Regulation (EU) No 596/2014 (the "Market Abuse Regulation") and Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation"). 

The Company reserves the right to make subsequent changes to the above terms for the program and will in such case make appropriate announcements in this respect. 

  

For further information, please contact: 
Richard Hallström, CFO 
Email: richard.hallstrom@contextvision.com 
 

About ContextVision  

ContextVision is a software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX. 

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-09-09 17:40 CEST.

Attachments
Initiation of share buyback program